Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28%

Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28%
SECTIONS
Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28%ETMarkets.com
Last Updated: Jul 30, 2021, 02:33 PM IST
Share
Synopsis
The company’s consolidated revenues in the quarter rose 28 per cent year-on-year to Rs 9,719 crore, which was sharply above analysts’ expectations.
Agencies
Analysts had expected the company to report consolidated net profit of Rs 1,470 crore for the reported quarter.
MUMBAI:
Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,444 crore for the quarter ended June as against a consolidated net loss of Rs 1,655 crore in the year-ago quarter. Analysts had expected the company to report consolidated net profit of Rs 1,470 crore for the reported quarter.

Related Keywords

Mumbai , Maharashtra , India , Sun Pharma , Dilip Shanghvi , Taro Pharmaceutical Industries , Us Department Of Justice , National Stock Exchange , Managing Director Dilip Shanghvi , National Stock , மும்பை , மகாராஷ்டிரா , இந்தியா , சூரியன் பார்மா , நீர்த்துப்போக ஷாங்க்வி , டாரோ மருந்து தொழில்கள் , எங்களுக்கு துறை ஆஃப் நீதி , தேசிய ஸ்டாக் பரிமாற்றம் , நிர்வகித்தல் இயக்குனர் நீர்த்துப்போக ஷாங்க்வி , தேசிய ஸ்டாக் ,